Abstract
How might increased funding and new initiatives help tackle the challenges of collecting and monitoring data on the safety of prescription drugs?
This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Jones, D. Keeping vigilant about drug safety. Nat Rev Drug Discov 6, 855–856 (2007). https://doi.org/10.1038/nrd2455
Issue Date:
DOI: https://doi.org/10.1038/nrd2455
- Springer Nature Limited
This article is cited by
-
Beyond debacle and debate: developing solutions in drug safety
Nature Reviews Drug Discovery (2009)
-
2007: Spotlight on drug safety
Nature Reviews Drug Discovery (2008)